new version V2017

Erlotinib EGFR inhibitors
Description Results

OSI-774 - CP-358774 - CP 358774 - Tarceva      

  • Group by...

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

lung cancer (metastatic)

OPTIMAL erlotinibPlatinum-based CTSuggesting NCT00874419
EUTRACerlotinibPlatinum-based CTSuggesting NCT00446225
TITANerlotinibPlatinum-based CTNegative NCT00556322
TRIBUTE (Herbst)erlotinib + Platinum-based CTPlatinum-based CTNegative
Gatzemeier erlotinib + Platinum-based CTPlatinum-based CTNegative
Mok erlotinib + Platinum-based CTPlatinum-based CTSuggesting
SATURN (Cappuzzo)erlotinib + Platinum-based CTPlatinum-based CTSuggesting NCT00556712
Boutsikouerlotinib + Platinum-based CTPlatinum-based CTNegative
Lee erlotinib + Platinum-based CTPlatinum-based CTSuggesting NCT00550173
Stinchcombeerlotinib + Platinum-based CTPlatinum-based CTNegative
FASTACT-2 (Wu) erlotinib + Platinum-based CTPlatinum-based CTSuggesting NCT00883779



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons